Multilateral trade deals—such as the Trans-Pacific Partnership touted by President Barack Obama on his recent trip through Asia—are usually of little concern or consequence to healthcare stakeholders. But the TPP could affect pharmaceutical pricing around the globe.
Corporate CEOs, attorneys, real estate moguls and other business leaders routinely serve on the boards of not-for-profit hospitals, systems and insurers. But some top executives at not-for-profit healthcare organizations also hold board seats at some of the largest publicly traded companies in the...
Over the past two decades, especially in the years since the ACA passed, there has been a gradual movement toward paying board members at national or regional hospital systems, integrated provider-payer organizations and insurers. And some of the payouts are quite substantial.
A half-century after formation of the Federation of American Hospitals, for-profit hospital chains have moved beyond a scandal-plagued past to forge a permanent place in the healthcare landscape that features both collaboration and competition with not-for-profit systems.
The investigation was groundbreaking in many respects, and providers will likely feel its effects for years to come—in ways that are both potentially positive and negative for the hospital community.
The Federation of American Hospitals has emerged as a potent lobbying force in Washington.
Physicians have increasingly looked to 3-D printing for unique implants and surgical models, and some manufacturers are now using the method to mass produce medical devices and even drugs that are more precise, customizable and biocompatible than conventionally produced products.
The rise of high-deductible health insurance is challenging providers across the country to change the way they prepare for and collect payments from people getting hit with large out-of-pocket costs for care.
Institutional investors are pushing for a range of reforms at publicly traded healthcare firms. High on the agenda is easier access to proxy ballots for an alternative slate of board directors.
The tax penalty and other measures designed to get younger, healthier people to sign up for individual plans on the ACA's insurance exchanges have not accomplished their mission of preventing adverse selection.
Some health and civil-rights advocates say guidelines that recommend women postpone breast cancer screenings until they are age 50 should not apply to black women, who are more likely to die if they contract the disease.
Hospitals—having spent the better part of the past decade working with their surgeons to narrow the variety of cardiovascular, orthopedic and other implants used in their operating rooms—are now looking for new ways to cut expenses related to these high-cost items.